Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Woerle Hans-Juergen — Seres Therapeutics, Inc. insider: 1 transactions · InsiderLens

Home / Insiders / Woerle Hans-Juergen

Woerle Hans-Juergen

Director at Seres Therapeutics, Inc. · on record since Feb 6, 2025

Insider trading activity of Woerle Hans-Juergen

Transactions on record: 1; since Feb 6, 2025

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Feb 6, 2025

Figures computed from official regulatory filings — methodology.

Companies where Woerle Hans-Juergen has traded

Seres Therapeutics, Inc.1 tx · Feb 6, 2025

Track record of Woerle Hans-Juergen

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Woerle Hans-Juergen

Co-insiders of Woerle Hans-Juergen

AFEYAN NOUBARSeres Therapeutics, Inc.
Arkowitz DavidSeres Therapeutics, Inc.
Aunins John G.Seres Therapeutics, Inc.
Ausiello Dennis ASeres Therapeutics, Inc.
Behar GregorySeres Therapeutics, Inc.
Berenson StephenSeres Therapeutics, Inc.
Biondi PaulSeres Therapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Brady KellySeres Therapeutics, Inc.

CAUTREELS WERNERSeres Therapeutics, Inc.

Chapman MarcusSeres Therapeutics, Inc.

Cloghessy PaulaSeres Therapeutics, Inc.

COOK DAVID NSeres Therapeutics, Inc.

Dere Willard HSeres Therapeutics, Inc.

DesRosier ThomasSeres Therapeutics, Inc.

Ege David S.Seres Therapeutics, Inc.

Flagship Pioneering Fund VI General Partner LLCSeres Therapeutics, Inc.

Flagship Pioneering Fund VII General Partner LLCSeres Therapeutics, Inc.

Flagship Pioneering Fund VII, L.P.Seres Therapeutics, Inc.

Flagship Pioneering Fund VI, L.P.Seres Therapeutics, Inc.

Flagship VentureLabs IV, LLCSeres Therapeutics, Inc.

Flagship Ventures 2007 General Partner LLCSeres Therapeutics, Inc.

Flagship Ventures Fund 2007, L.P.Seres Therapeutics, Inc.

Flagship Ventures Fund IV General Partner LLCSeres Therapeutics, Inc.

Flagship Ventures Fund IV, L.P.Seres Therapeutics, Inc.

Flagship Ventures Fund IV-Rx, L.P.Seres Therapeutics, Inc.

Flagship Ventures Management, Inc.Seres Therapeutics, Inc.

Fraser-Liggett ClaireSeres Therapeutics, Inc.

Graves KurtSeres Therapeutics, Inc.

Hashad WaelSeres Therapeutics, Inc.

Henn Matthew RSeres Therapeutics, Inc.

HORGAN KEVINSeres Therapeutics, Inc.

HUTT PETER BARTONSeres Therapeutics, Inc.

KANIA EDWIN M JRSeres Therapeutics, Inc.

Kender Richard NSeres Therapeutics, Inc.

Kim Lorence H.Seres Therapeutics, Inc.

Nestle Health Science US Holdings, Inc.Seres Therapeutics, Inc.

NESTLE SASeres Therapeutics, Inc.

NIMCO US, Inc.Seres Therapeutics, Inc.

Nutritional Health LTP Fund General Partner LLCSeres Therapeutics, Inc.

Nutritional Health LTP Fund, L.P.Seres Therapeutics, Inc.

Pomerantz RogerSeres Therapeutics, Inc.

Rosiello Robert L.Seres Therapeutics, Inc.

Shaff Eric D.Seres Therapeutics, Inc.

Societe des Produits Nestle S.A.Seres Therapeutics, Inc.

Thorell MarellaSeres Therapeutics, Inc.

Trucksis MicheleSeres Therapeutics, Inc.

von Moltke LisaSeres Therapeutics, Inc.

Young Teresa L.Seres Therapeutics, Inc.

Zausner MerylSeres Therapeutics, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Seres Therapeutics, Inc.	Feb 6, 2025	AwardD	120,000	0.00 USD	$0	SEC